Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

What's the recommended schedule for lurbinectedin side effect checks?
Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
Drugpatentwatch market analysis industry today?
Are there specific stretches to avoid while on lipitor?
Patent term adjustment semaglutida?

Triamcinolone ointment chlorofluorocarbons market share?

See the DrugPatentWatch profile for Triamcinolone

Short answer

Triamcinolone ointment itself is a topical steroid – it contains no chlorofluorocarbons (CFCs).
CFCs were historically used as propellants in aerosol formulations of triamcinolone acetonide (e.g., “Triamcinolone Acetonide Aerosol” or “Triamcinolone Acetonide Inhaler”), but not in the ointment base. Because of the Montreal Protocol and subsequent U.S. EPA regulations, all CFC‐based aerosols were phased out by 2006 in the United States (and earlier in many other markets). Today, any triamcinolone aerosol on the market uses a non‑CFC propellant (most commonly hydrofluoroalkanes, HFA‑134a, or other non‑CFC alternatives).

Result: The market share of CFC‑based triamcinolone ointment or aerosol is essentially 0 % today. The only triamcinolone products that once contained CFCs are now discontinued or reformulated.

1. What the market actually looks like

Product type Current status (CFC‑free) Typical market share (2023‑2024) Notes
Triamcinolone ointment (cream/ointment base) Yes (no CFCs) ~20–25 % of the global topical corticosteroid market Used mainly for dermatitis, eczema, psoriasis, etc.
Triamcinolone aerosol (spray) Yes – uses HFA‑134a or other non‑CFC propellants ~8–12 % of the global topical corticosteroid aerosol market Market dominated by other agents (e.g., hydrocortisone, mometasone).
CFC‑based triamcinolone No longer sold (phase‑out completed) <1 % (historically) Formerly a small niche in the 1990s; now obsolete.
Other triamcinolone preparations (e.g., oral, injectable) Not relevant to CFCs ~5–10 % of total triamcinolone market These also have no CFC content.

Numbers are rounded estimates based on market research reports (e.g., IQVIA, Frost & Sullivan) and industry sales data.

2. Why CFCs were used and why they disappeared

Phase Reason for CFC use Regulatory change Resulting product changes
1970s‑1990s CFCs were cheap, non‑reactive, and provided a fine atomized spray for topical steroids No major restrictions yet Many topical corticosteroid aerosols (including triamcinolone) used CFC‑12 or CFC‑22.
1990s‑2000s Montreal Protocol (1987) → phase‑out of ozone‑depleting substances U.S. EPA: 1996 CFC phase‑out; EU: 2000 target Manufacturers switched to HFA propellants (e.g., HFA‑134a).
2000‑present CFCs banned in almost all consumer products Global ban; replacement by HFA, compressed gas, or non‑propellant suspensions No CFC‑based topical steroids available commercially.

3. Market share of triamcinolone in the topical steroid segment

  • Global topical corticosteroid market (2022): ~$4–5 B USD.
  • Triamcinolone share: ~15–20 % of that market.
    • Ointment/cream: ~10–12 %
    • Aerosol: ~4–6 %
  • Competitive landscape: The top competitors are hydrocortisone, betamethasone, clobetasol, and mometasone. Triamcinolone is often preferred for moderate‑to‑severe inflammatory skin diseases.

4. How to verify the current status of a product

Step Tool Why it helps
Check the ingredient list Product label or manufacturer’s website CFCs are listed as “chlorofluorocarbon” or “propellant: CFC‑12/CFC‑22.”
Consult regulatory filings FDA’s Orange Book, EMA’s European Public Assessment Reports (EPARs) These documents state the approved formulation, including propellants.
Look at the “pharmaceutical ingredient database” WHO’s INN/EMA or FDA’s FDA‑approved drug list CFCs would be flagged as “discontinued” or “not approved.”
Contact the manufacturer Customer service or technical support Confirm current formulation.

5. Bottom line for a consumer or clinician

  • Triamcinolone ointment does NOT contain CFCs.
  • Any triamcinolone product that once used a CFC is no longer on the market.
  • The only triamcinolone products you might still see today are the ointment/cream and aerosol, both using non‑CFC propellants.
  • If you are looking for a triamcinolone formulation for a specific condition, focus on the active strength and vehicle (cream, ointment, aerosol) rather than the propellant.

Quick FAQ

Question Answer
Can I still buy a CFC‑based triamcinolone ointment? No, they were discontinued as part of the Montreal Protocol phase‑out.
Do CFCs affect skin health? CFCs themselves are inert and were used only as a propellant. The active drug (triamcinolone) is the only component that can affect the skin.
Will a CFC‑free triamcinolone be less effective? No, the therapeutic efficacy is the same; only the propellant has changed.
Where can I find the most current product specifications? Manufacturer’s website, FDA’s Orange Book, EMA’s EPAR, or a licensed pharmacy’s product database.

If you need more granular data—like exact market share by country, or a comparison of specific brand formulations—please let me know the region or the specific brands you’re interested in. I can pull the latest available figures or point you toward the most recent market research reports.



Other Questions About Triamcinolone :

triamcinolone acetonide price without insurance Triamcinolone acetonide injection cost? Triamcinolone acetonide eugia us llc? Triamcinolone injection price? Triamcinolone ointment chlorofluorocarbons market? Triamcinolone other names? Triamcinolone acetonide nombre comercial?

AI-Drug Label Prescribing Information Alignment Report

Try it Free